Changing the Conversation on Adult Influenza Vaccination: United States
US campaign is the good example of how to extensively promote influenza vaccination without the basis of universal influenza vaccination program. Although annual influenza vaccination is recommended for all people aged 6 months and over, the influenza vaccine is covered by private health insurance plans and the government-funded program is only eligible for adults aged 65 years and over (Medicare Part B).
CDC is leading the national influenza awareness campaign and has developed a great deal of communication resources including web assets, factsheets, infographics, posters, videos, podcasts, social media toolkits, news releases and so on. All materials are downloadable, shareable, and some of them are customizable to assist partners in spreading the messages to promote the awareness of influenza vaccination.
Although there has been an emphasis on universal communication for all people aged 6 months and older, CDC is still committed to reaching high-risk people influenza, including older people and adults with chronic disease, by creating targeted informative and education materials.
As a complementary part of government campaign, a lot of patients organizations and advocacy groups are rolling out targeted campaigns and sharing tailored messages to inform their members and constitutes about the seriousness of influenza and the importance of vaccination.
Campaign Overview: United States Report
View the report providing an overview of
the adult influenza campaign in the United States.
USA Resources

Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings.
The ‘Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care’ study was conducted to understand the status of existing public health policies and campaigns on pneumococcal disease in community and long-term care settings and its implications on the uptake of pneumococcal vaccination. The report highlights policy gaps for pneumococcal vaccination across long-term care settings in Canada and accordingly provides recommendations for policy improvements.
Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings. Check out the technical report to learn more.